CytomX Therapeutics (CTMX) Revenue (2014 - 2026)
CytomX Therapeutics (CTMX) revenue from Sep 30, 2014 to Mar 31, 2026. The TTM CytomX Therapeutics (CTMX) revenue is $68M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
CytomX Therapeutics (CTMX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -88.56% |
| 3 Years TTM | -37.04% |
| 5 Years TTM | -24.04% |
| 10 Years TTM | +7.50% |
| All Time TTM | +10.86% |
Annual Revenue change of CytomX Therapeutics (CTMX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $10M | -86.54% |
| 2025 | $76M | -44.82% |
| 2024 | $138M | +36.45% |
| 2023 | $101M | +90.39% |
| 2022 | $53M | +42.48% |
| 2021 | $37M | -62.82% |
| 2020 | $100M | +1112.08% |
| 2019 | $8.28M | -86.08% |
| 2018 | $60M | -16.92% |
| 2017 | $72M | +457.35% |
| 2016 | $13M | +66.67% |
| 2015 | $7.71M | +51.77% |
| 2014 | $5.08M | +470.79% |
| 2013 | $890K | N/A |
Comparison CytomX Therapeutics (CTMX) five years revenue CAGR with competitors
CytomX Therapeutics (CTMX) five years revenue CAGR is -7.54%.